| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.04 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.04 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.16 | 0.05 |